Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

We need an evidence-based, randomized trial on gun control

Ryan Madanick, MD
Physician
February 25, 2013
Share
Tweet
Share

For just a moment, let’s take a scientific viewpoint about gun control here and try to leave emotions (and the Constitutional argument) out.

The best type of study to determine whether gun control and/or regulation would be a randomized trial: randomizing a state or country to regulation or not.

Since that’s not going to happen, the next best type of evidence we have to go by is observational, either case-control or cohort studies. The exposure is: gun control regulation. This could be considered dichotomously (yes/no) or continuous (level of regulation from strict to lenient/none).

The outcome is: death by guns. This could be considered in numerous ways: absolute numbers of gun deaths annually; relative numbers of gun deaths adjusting for size of population; number of gun massacres, etc. We could even consider any violent deaths, if you want to be more general.

In a case-cohort study, we’d look at the outcome first (let’s say, massacres) and look backward for the exposure, then calculate an odds ratio that the outcome was significantly associated with the exposure.

In a cohort study, we’d look at the exposure first, looking at level of gun control as a continuous variable. This could be done retrospectively or prospectively. As of now, we could only do this retrospectively. Then look for the outcomes (deaths, massacres, etc.), and determine a risk ratio that the outcome was associated with the exposure.

Either way, the data would indicate that countries with increased exposure (increasing regulation) is associated with a decreased odds/risk of the outcome (fewer deaths, massacres).

Please note that I did not say that increasing regulation caused fewer deaths, just that it was associated with fewer deaths.

Now, I do not have numerical data, so I am only going on what I understand to be true, the empirical data. If those who would not believe this to be true, the best way to deal with this is to show data that decreasing the exposure to gun regulation (i.e., increasing the populace’s ability to acquire firearms legally) is associated with fewer gun deaths.

Therefore, my preference is the following: until evidence (not raw emotions, beliefs, or Constitutional Amendments) that decreased regulation (including eliminating gun zones) results in decreased odds/risk for the outcome (gun death) is found in other countries, then there is no reason to accept the notion that we need to stop advocating for strict gun control. For that matter, stricter gun control has evidential support (even if not emotional support among some) and should be advanced.

If you choose to comment on this in the opposite direction, please think before you do. The anecdotal evidence currently being provided by those who would oppose stricter regulations is purely speculative. I am open to hearing the data to refute the above contention, but it needs to be at least as strong methodologically.

In other words, “case reports” (testimonials by individuals) or “case series” (testimonials by groups, including lobbyists) are weaker forms of evidence scientifically, and I will not consider them as valid as the comparative empirical data I have put forward as an argument.

Ryan Madanick is a gastroenterologist who blogs at Gut Check.

ADVERTISEMENT

Prev

Smoking has become hidden in the shadow of obesity

February 25, 2013 Kevin 4
…
Next

Are generic drugs as safe and effective as name brand drugs?

February 26, 2013 Kevin 11
…

Tagged as: Primary Care

Post navigation

< Previous Post
Smoking has become hidden in the shadow of obesity
Next Post >
Are generic drugs as safe and effective as name brand drugs?

ADVERTISEMENT

More by Ryan Madanick, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Medical educators: A subtle difference in wording makes a difference

    Ryan Madanick, MD
  • a desk with keyboard and ipad with the kevinmd logo

    How to get started on Twitter: A primer for doctors

    Ryan Madanick, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Billing an established patient visit as a consultation

    Ryan Madanick, MD

More in Physician

  • Blackballing in medicine: a physician’s story

    Ronald L. Lindsay, MD
  • Modern eugenics: the quiet return of a dangerous ideology

    Arthur Lazarus, MD, MBA
  • The problem with perfectionism in health care

    Amna Shabbir, MD
  • The inconsistent academic peer review process

    V. Sushma Chamarthi, MD
  • Physician end-of-year reflection: Growing through challenges

    Stephanie Wellington, MD
  • How online parent communities extend care

    Jorge Rodriguez, MD
  • Most Popular

  • Past Week

    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • Alcohol, dairy, and breast cancer risk

      Neal Barnard, MD | Conditions
    • The erosion of evidence-based medicine: a doctor’s warning

      Corinne Sundar Rao, MD | Physician
    • Testosterone cardiovascular risk: FDA update 2025

      Martina Ambardjieva, MD, PhD | Meds
    • Blackballing in medicine: a physician’s story

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Stop doing peer reviews for free

      Vijay Rajput, MD | Education
  • Recent Posts

    • Blackballing in medicine: a physician’s story

      Ronald L. Lindsay, MD | Physician
    • Physician advocacy as a core clinical skill

      Tyler D. Harvey, MPH | Education
    • Phytotherapy for kidney stones: a clinical review

      Martina Ambardjieva, MD, PhD | Uncategorized
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
    • The liver’s role in metabolic disease

      Martin Grajower, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 21 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • Alcohol, dairy, and breast cancer risk

      Neal Barnard, MD | Conditions
    • The erosion of evidence-based medicine: a doctor’s warning

      Corinne Sundar Rao, MD | Physician
    • Testosterone cardiovascular risk: FDA update 2025

      Martina Ambardjieva, MD, PhD | Meds
    • Blackballing in medicine: a physician’s story

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Stop doing peer reviews for free

      Vijay Rajput, MD | Education
  • Recent Posts

    • Blackballing in medicine: a physician’s story

      Ronald L. Lindsay, MD | Physician
    • Physician advocacy as a core clinical skill

      Tyler D. Harvey, MPH | Education
    • Phytotherapy for kidney stones: a clinical review

      Martina Ambardjieva, MD, PhD | Uncategorized
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
    • The liver’s role in metabolic disease

      Martin Grajower, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

We need an evidence-based, randomized trial on gun control
21 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...